Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 490
of 25Next
1:
Related Articles, Links
Robson ME, Chappuis PO, Satagopan J, Wong N, Boyd J, Goffin JR, Hudis C, Roberge D, Norton L, Bégin LR, Offit K, Foulkes WD.
Free in PMC
A combined analysis of outcome following breast cancer: differences in survival based on BRCA1/BRCA2 mutation status and administration of adjuvant treatment.
Breast Cancer Res. 2004;6(1):R8-R17. Epub 2003 Oct 24.
PMID: 14680495 [PubMed - indexed for MEDLINE]
2:
Related Articles, Links
Robson M, Levin D, Federici M, Satagopan J, Bogolminy F, Heerdt A, Borgen P, McCormick B, Hudis C, Norton L, Boyd J, Offit K.
Free Full Text
Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.
J Natl Cancer Inst. 1999 Dec 15;91(24):2112-7.
PMID: 10601383 [PubMed - indexed for MEDLINE]
3:
Related Articles, Links
Chappuis PO, Donato E, Goffin JR, Wong N, Bégin LR, Kapusta LR, Brunet JS, Porter P, Foulkes WD.
Free Full Text
Cyclin E expression in breast cancer: predicting germline BRCA1 mutations, prognosis and response to treatment.
Ann Oncol. 2005 May;16(5):735-42. Epub 2005 Mar 31.
PMID: 15802279 [PubMed - indexed for MEDLINE]
4:
Related Articles, Links
Goffin JR, Chappuis PO, Bégin LR, Wong N, Brunet JS, Hamel N, Paradis AJ, Boyd J, Foulkes WD.
Free Full Text
Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data.
Cancer. 2003 Feb 1;97(3):527-36.
PMID: 12548593 [PubMed - indexed for MEDLINE]
5:
Related Articles, Links
Foulkes WD, Chappuis PO, Wong N, Brunet JS, Vesprini D, Rozen F, Yuan ZQ, Pollak MN, Kuperstein G, Narod SA, Bégin LR.
Free Full Text
Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.
Ann Oncol. 2000 Mar;11(3):307-13.
PMID: 10811497 [PubMed - indexed for MEDLINE]
6:
Related Articles, Links
Chappuis PO, Kapusta L, Bégin LR, Wong N, Brunet JS, Narod SA, Slingerland J, Foulkes WD.
Abstract
Germline BRCA1/2 mutations and p27(Kip1) protein levels independently predict outcome after breast cancer.
J Clin Oncol. 2000 Dec 15;18(24):4045-52.
PMID: 11118465 [PubMed - indexed for MEDLINE]
7:
Related Articles, Links
Satagopan JM, Boyd J, Kauff ND, Robson M, Scheuer L, Narod S, Offit K.
Free Full Text
Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
Clin Cancer Res. 2002 Dec;8(12):3776-81.
PMID: 12473589 [PubMed - indexed for MEDLINE]
8:
Related Articles, Links
Rennert G, Bisland-Naggan S, Barnett-Griness O, Bar-Joseph N, Zhang S, Rennert HS, Narod SA.
Free Full Text
Clinical outcomes of breast cancer in carriers of BRCA1 and BRCA2 mutations.
N Engl J Med. 2007 Jul 12;357(2):115-23.
PMID: 17625123 [PubMed - indexed for MEDLINE]
9:
Related Articles, Links
Hodgson SV, Heap E, Cameron J, Ellis D, Mathew CG, Eeles RA, Solomon E, Lewis CM.
Free in PMC
Risk factors for detecting germline BRCA1 and BRCA2 founder mutations in Ashkenazi Jewish women with breast or ovarian cancer.
J Med Genet. 1999 May;36(5):369-73.
PMID: 10353781 [PubMed - indexed for MEDLINE]
10:
Related Articles, Links
Kirova YM, Stoppa-Lyonnet D, Savignoni A, Sigal-Zafrani B, Fabre N, Fourquet A; for the Institut Curie Breast Cancer Study Group.
Abstract
Risk of breast cancer recurrence and contralateral breast cancer in relation to BRCA1 and BRCA2 mutation status following breast-conserving surgery and radiotherapy.
Eur J Cancer. 2005 Oct;41(15):2304-11. Epub 2005 Sep 1.
PMID: 16140006 [PubMed - indexed for MEDLINE]
11:
Related Articles, Links
Struewing JP, Hartge P, Wacholder S, Baker SM, Berlin M, McAdams M, Timmerman MM, Brody LC, Tucker MA.
Free Full Text
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews.
N Engl J Med. 1997 May 15;336(20):1401-8.
PMID: 9145676 [PubMed - indexed for MEDLINE]
12:
Related Articles, Links
Levy-Lahad E, Lahad A, Eisenberg S, Dagan E, Paperna T, Kasinetz L, Catane R, Kaufman B, Beller U, Renbaum P, Gershoni-Baruch R.
Free in PMC
A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers.
Proc Natl Acad Sci U S A. 2001 Mar 13;98(6):3232-6.
PMID: 11248061 [PubMed - indexed for MEDLINE]
13:
Related Articles, Links
McLaughlin JR, Risch HA, Lubinski J, Moller P, Ghadirian P, Lynch H, Karlan B, Fishman D, Rosen B, Neuhausen SL, Offit K, Kauff N, Domchek S, Tung N, Friedman E, Foulkes W, Sun P, Narod SA; Hereditary Ovarian Cancer Clinical Study Group.
Abstract
Reproductive risk factors for ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.
Lancet Oncol. 2007 Jan;8(1):26-34.
PMID: 17196508 [PubMed - indexed for MEDLINE]
14:
Related Articles, Links
Haffty BG, Harrold E, Khan AJ, Pathare P, Smith TE, Turner BC, Glazer PM, Ward B, Carter D, Matloff E, Bale AE, Alvarez-Franco M.
Abstract
Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.
Lancet. 2002 Apr 27;359(9316):1471-7.
PMID: 11988246 [PubMed - indexed for MEDLINE]
15:
Related Articles, Links
Gal I, Gershoni Baruch R, Haber D, Dagan E, Eisenberg-Barzilai S, Zidan J, Friedman E.
Abstract
The 1100delAT BRCA1 and the 8765delAG BRCA2 mutations: occurrence in high-risk non-Ashkenazi Jews and haplotype comparison of Jewish and non-Jewish carriers.
Fam Cancer. 2004;3(1):11-4.
PMID: 15131400 [PubMed - indexed for MEDLINE]
16:
Related Articles, Links
Hamel N, Kotar K, Foulkes WD.
Free in PMC
Founder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancer.
BMC Med Genet. 2003 Aug 11;4:7.
PMID: 12911837 [PubMed - indexed for MEDLINE]
17:
Related Articles, Links
Lee JS, Wacholder S, Struewing JP, McAdams M, Pee D, Brody LC, Tucker MA, Hartge P.
Free Full Text
Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst. 1999 Feb 3;91(3):259-63.
PMID: 10037104 [PubMed - indexed for MEDLINE]
18:
Related Articles, Links
Frank TS, Deffenbaugh AM, Reid JE, Hulick M, Ward BE, Lingenfelter B, Gumpper KL, Scholl T, Tavtigian SV, Pruss DR, Critchfield GC.
Abstract
Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
J Clin Oncol. 2002 Mar 15;20(6):1480-90.
PMID: 11896095 [PubMed - indexed for MEDLINE]
19:
Related Articles, Links
Chodick G, Struewing JP, Ron E, Rutter JL, Iscovich J.
Free in PMC
Similar prevalence of founder BRCA1 and BRCA2 mutations among Ashkenazi and non-Ashkenazi men with breast cancer: evidence from 261 cases in Israel, 1976-1999.
Eur J Med Genet. 2008 Mar-Apr;51(2):141-7. Epub 2007 Nov 22.
PMID: 18158280 [PubMed - indexed for MEDLINE]
20:
Related Articles, Links
McClain MR, Nathanson KL, Palomaki GE, Haddow JE.
Abstract
An evaluation of BRCA1 and BRCA2 founder mutations penetrance estimates for breast cancer among Ashkenazi Jewish women.
Genet Med. 2005 Jan;7(1):34-9.
PMID: